About a hundred, to be specific
Its a common experience, and it doesnt mean the medication isnt working
Why this trial matters: First triple hormone receptor agonist showing major Phase III weight-loss efficacy Delivers weight-loss outcomes far beyond many current therapies Suggests a potential new metabolic and obesity care benchmark Semaglutide Shows Consistent Liver Benefits in MASH In the Phase III ESSENCE study, once-weekly semaglutide 2.4 mg significantly increased rates of steatohepatitis resolution and fibrosis improvement on liver biopsy in adults with metabolic dysfunction-associated steatohepatitis (MASH), compared with placebo
Combined with sensitivity analyses, we infer that the imprecision leading to downgraded evidence quality for certain outcomes may be linked to differences in study follow-up duration: short-term follow-up studies might suffer from increased random error or insufficient statistical power due to inadequate accumulation of cardiovascular events
Having a medical professional available to discuss headaches , constipation , fatigue , or other side effects without scheduling a separate appointment or paying extra is a genuine benefit
Youll likely start at the 0.25 mg dose and increase every four weeks until you reach a maintenance Wegovy dosage , as determined by your healthcare provider